View source for 20140122 HL7 PLA Meeting

return to [[HL7 Product Line Architecture Meeting Minutes and Agendas]]<br/>
Return to [[HL7 Product Line Architecture ]] Program
{|border="1" cellpadding="2" cellspacing="0" 
<!---=======================================================================
|                                                                          |
|   MM     MM  TTTTTT   GGGGG        IIIIII  NN    NN  FFFFFF   OOOOO      |
|   MMM   MMM    TT    GG              II    NNN   NN  FF      OO   OO     |
|   MM MMM MM    TT    GG  GGG         II    NN NN NN  FFFF    OO   OO     |
|   MM  M  MM    TT    GG   GG         II    NN   NNN  FF      OO   OO     |
|   MM     MM    TT     GGGGG        IIIIII  NN    NN  FF       OOOOO      |
|                                                                          |
========================================================================--->
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 PLA Call Minutes''' <br/>
'''Location: ''' Room TBD
| colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2014-01-22'''<br/> '''Time: 1:45 PM Central (Q3)'''
|-
| colspan="1" align="right"|'''Facilitator'''
| colspan="1" align="left"|Austin Kreisler
| colspan="1" align="right"|'''Note taker(s)'''
| colspan="1" align="left"| Lynn
|-
| border="4" cellpadding="1" colspan="4" style="background:#f0f0f0;"|
|-
|}
{|border="1" cellpadding="2" cellspacing="0" 
| border="1" cellpadding="2" colspan="1" align="left"|'''Attendee'''
| '''Name'''


<!---==============================================================================
|                                                                                 |
|    AAAA   TTTTTT  TTTTTT  EEEEEE  NN    NN  DDDDD    EEEEEE  EEEEEE   SSSSS     |
|   AA  AA    TT      TT    EE      NNN   NN  DD   DD  EE      EE      SS         |
|   AAAAAA    TT      TT    EEEE    NN NN NN  DD   DD  EEEE    EEEE     SSSS      |
|   AA  AA    TT      TT    EE      NN   NNN  DD   DD  EE      EE          SS     |
|   AA  AA    TT      TT    EEEEEE  NN    NN  DDDDD    EEEEEE  EEEEEE  SSSSS      |
|                                                                                 |
===============================================================================--->
|-
| || Calvin Beebe
|-
| || Woody Beeler 
|-
| ||Lorraine Constable
|-
| || Jane Curry
|-
| ||Bo Dagnall
|-
| || Jean Duteau,
|-
| || Tony Julian 
|-
| || Paul Knapp
|-
| || Austin Kreisler,
|-
| || Lynn Laakso
|-
| || Don Lloyd
|-
| || Ken McCaslin
|-
| || Ron Parker
|-
| || Brian Pech
|-
| || John Quinn
|-
|colspan="4" style="background:#f0f0f0;"|
|-
|colspan="4" style="font-style:italic; color:green;" |''no quorum definition''

|}
<!---=======================================================
|                                                          |
|    AAAA    GGGGG   EEEEEE  NN    NN  DDDDD     AAAA      |
|   AA  AA  GG       EE      NNN   NN  DD   DD  AA  AA     |
|   AAAAAA  GG  GGG  EEEE    NN NN NN  DD   DD  AAAAAA     |
|   AA  AA  GG   GG  EE      NN   NNN  DD   DD  AA  AA     |
|   AA  AA   GGGGG   EEEEEE  NN    NN  DDDDD    AA  AA     |
|                                                          |
========================================================--->
===Agenda===
Agenda review
*Notes of [[20131211 PLA call]] review
*Map our existing products into notional division of products into product families and lines, to provide examples for peer review.
**Level of granularity
**Identify which pieces are orphaned, and the political elements to be surfaced.
**Positioning cross-product family artifacts (standards naming)
*BAM-lite feedback and review 
**Governance on V2.x (v2.9 substantive changes)
**develop form to request establishing a Product Family 

 
===Minutes===
Agenda review - Ken had discussed with Austin that we need to review everything under standards on the website and categorize them into preliminary concepts of product families and lines in order to figure out how to move forward.
*Map our existing products into notional division of products into product families and lines, to provide examples for peer review.
**Is certification a product? Is it something that is an artifact that allows you to achieve interoperability. 
**Outward facing collection of items for consumability is product line. Coherent collection from a consumability perspective is product line. 
**FHIR architecture is a product family - Production perspective.

Product Family
*FHIR
*V2
*V3
*vMR-CDS
*EHR-S FM
*Arden Syntax
*CCOW
*GELLO
*DAM? Are they a product family? With the ArB definition should share common method of production. Analytical viewpoint from where requirements are derived. Most DAMs also have use cases in them. What do we call them - "Analysis Artifacts"? Methodology ans structure for how they are produced is coherent. It is at a higher level on the ECCF than other products. 
*Templates? are structures in V2 considered a template? V3 has templates mechanism being defined, CDA also has structured data templates. It is intended to feed into reuse, constraint or extensibility. 
*Conformance and certification - conformance assertions skillset and methodology should be consistent across paradigms. Ron notes that some WGs may have to reframe thinking the application of methodology. 
**Certification is individual conformance to HL7's established standards of performance notes Ken. Ron agrees that certification is adherence to standards of conformance. John suggests you might regard it as managing optionality. 







{|border="1" cellpadding="2" cellspacing="0" 
|-
|colspan=6|             Product Family
|-
|Product Line ||FHIR||V3||V2||DAM||CDA
|-
|? || ||RIM || || || C-CDA
|-
| e.g. || C-CDA || || C-CDA
|-
| Lab|| ||LRI IG<br/>LOI IG<br/>eDOS IG||LAB DAM ||C-CDA
|-
|S&I/MU <br/> US Realm|| || LRI IG<br/>LOI IG<br/>eDOS IG|| ||C-CDA

|-
|
|-
|

|}

===Meeting Outcomes===
{|border="1" cellpadding="2" cellspacing="0" 
|-
<!---==============================================================
|                                                                 |
|    AAAA    CCCCC  TTTTTT  IIIIII   OOOOO   NN    NN   SSSSS     |
|   AA  AA  CC        TT      II    OO   OO  NNN   NN  SS         |
|   AAAAAA  CC        TT      II    OO   OO  NN NN NN   SSSS      |
|   AA  AA  CC        TT      II    OO   OO  NN   NNN      SS     |
|   AA  AA   CCCCC    TT    IIIIII   OOOOO   NN    NN  SSSSS      |
|                                                                 |
===============================================================--->

| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
*

|-
<!---=======================================================================
|                                                                          |
|   NN    NN  EEEEEE  XX   XX  TTTTTT       MM     MM  TTTTTT   GGGGG      |
|   NNN   NN  EE       XX XX     TT         MMM   MMM    TT    GG          |
|   NN NN NN  EEEE      XXX      TT         MM MMM MM    TT    GG  GGG     |
|   NN   NNN  EE       XX XX     TT         MM  M  MM    TT    GG   GG     |
|   NN    NN  EEEEEE  XX   XX    TT         MM     MM    TT     GGGGG      |
|                                                                          |
========================================================================--->

|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
*TBD

|}

© 2014 Health Level Seven® International.  All rights reserved